
Company Info
Year Established2017
Ticker
QTTB
Exchange
NASDAQ
Contacts
Jodie MorrisonCEO
Shelia Violette, Ph.D.
Founder & CSO
Jason Campagna, M.D., Ph.D.
CMO
Lee Kalowski
President & CFO
Company Description
Q32 Bio is developing drugs targeting powerful regulators of both the innate and adaptive immune systems with the goal of re-balancing the immune system.